Effects of an antigastrin compound on induced gastric hypersecretion in dogs.
D000818:Animals; D004285:Dogs; D005747:Gastric Fistula; D005753:Gastric Mucosa / Q000378:metabolism*; D005755:Gastrins / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D006601:Hexoses / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007422:Intestines / Q000601:surgery; D010183:Pancreatic Ducts / Q000601:surgery; D010648:Phenylacetates / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D013270:Stomach / Q000601:surgery; D013438:Sulfhydryl Compounds / Q000494:pharmacology*
D005755:Gastrins; D006601:Hexoses; D010648:Phenylacetates; D011725:Pyridines; D013438:Sulfhydryl Compounds; D006632:Histamine